new treatments for breast cancer

Release time ：Dec-27,2024

Novel approaches to treating breast cancer commonly encompass targeted therapies, immunotherapies, and hormonal treatments. These therapeutic strategies may be employed individually or in tandem to enhance treatment efficacy and minimize adverse effects.

Targeted therapy, for instance, involves the precise targeting of specific molecular markers on cancer cells, thereby reducing harm to healthy cells. Patients with HER2-positive breast cancer can benefit from targeted drugs that specifically target the HER2 protein. Immunotherapy, on the other hand, leverages the patient's immune system to recognize and combat cancer cells. Clinical trials have demonstrated that certain immunotherapies show promise in treating hard-to-treat breast cancers, such as triple-negative breast cancer. Hormonal therapy is primarily indicated for patients with hormone receptor-positive breast cancer, functioning by blocking estrogen's effects or reducing estrogen levels to inhibit tumor growth.

Selecting the right treatment for breast cancer patients necessitates consideration of individual circumstances and tumor profiles. Consequently, prior to initiating any treatment, patients should undergo a comprehensive evaluation and diagnosis under a physician's supervision. Additionally, it is imperative for patients to adhere to their doctor's recommendations for regular follow-ups and monitoring to facilitate timely adjustments to their treatment regimen.